Kineta Viral Hemorrhagic Fever, LLC
Biotechnology company · Seattle, Washington, United States
Kineta Viral Hemorrhagic Fever, LLC is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $33,750 sold in a notice filed in 2017.
Kineta Viral Hemorrhagic Fever at a glance
What does Kineta Viral Hemorrhagic Fever do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $33,750 sold (2017).
Frequently asked questions about Kineta Viral Hemorrhagic Fever
Where is Kineta Viral Hemorrhagic Fever headquartered?
Kineta Viral Hemorrhagic Fever, LLC is headquartered in Seattle, Washington, United States.
What does Kineta Viral Hemorrhagic Fever do?
Kineta Viral Hemorrhagic Fever, LLC is a biotechnology company.
When was Kineta Viral Hemorrhagic Fever founded?
The earliest incorporation on record for Kineta Viral Hemorrhagic Fever, LLC is in 2013, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences